Lorrin Koran
Academic Appointments
- Emeritus Faculty, Acad Council, Psychiatry & Behavioral Science
Contact Information
-
Clinical Offices
OCD Clinic 401 Quarry Rd MC 5723 Stanford, CA 94305 Tel Work (650) 723-2423 Fax (650) 725-0363
-
Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Psychiatry
- Trichotillomania
- skin picking
- compulsive buying
Administrative Appointments
- Director, Stanford OCD Clinic (1990 - present)
Honors and Awards
- Outstanding Achievement Award, Northern California Psychiatric Society (2004)
- Distinguished Life Fellow, American Psychiatric Association (2003)
- M.D., cum laude, Harvard Medical School (1966)
Professional Education
| Board Certification: | Psychiatry, American Board of Psychiatry and Neurology (1973) |
| Residency: | Stanford University Medical Center, CA (1970) |
| Internship: | UCLA Medical Center, CA (1967) |
| Medical Education: | Harvard Medical School, MA (1966) |
| M.D.: | Harvard Medical School, (1966) |
Community & International Work
Web Site Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Forest Pharmaceuticals Speakers Bureau |
Scientific Focus
Research Interests
1. Novel drug treatments for treatment-resistant obsessive-compulsive disorder (OCD).
2. Novel drug treatments for major depression
3. Drug treatments for impulse control disorders
Clinical Trials
- Open label trial of aripiprazole in Trichotillomania. Recruiting
- Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction Recruiting
- Dextro-Amphetamine versus Caffeine in Treatment-resistant OCD Completed
- Duloxetine for the Treatment of Dysthymia Completed
- Study of SEP-225441 in Subjects with Generalized Anxiety Disorder No longer recruiting
Publications
- Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2009
- The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectr. 2008; (4): 316-22
- Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients. J Clin Psychiatry. 2008; (12): 1856-9
- Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation. J Clin Psychiatry. 2007; (3): 422-7
- Duloxetine treatment of dysthymia and double depression: an open-label trial. J Clin Psychiatry. 2007; (5): 761-5
Help